GET A QUOTE

Fibroblast Growth Factor-9 (FGF9) ELISA Kit

  • Created on the 6 February, 2017.

BACKGROUND

Fibroblast growth factor-9 (FGF-9) is a steroid-regulated mitogen and possesses a broad range of cell survival and mitogenic activities that can be involved in a number of different biological processes such as cell growth, morphogenesis, tissue repair, invasion, embryonic development and tumor growth. Human FGF-9 cDNA has been cloned using oligonucleotide probes that encode a polypeptide consisting of 208 amino acids and it share approx. 30% sequence similarity to the other FGF family members.

FGF9 is produced and secreted by the prostatic stromal cells, it is a survival factor for mesenchymal or nerve cells and a potent mitogen activator for both prostatic stromal or epithelial cells in culture. FGF-9 is a growth factor that is abundantly secreted and can act as either an autocrine mitogen for stromal cells or a paracrine mitogen for epithelial cells. There is evidence that overexpression of this growth factor can play a vital role in epithelial or stromal proliferation in benign prostatic hyperplasia. The standard that is used in this ELISA assay is a recombinant human FGF9 that is made up of 208 amino acids and has a molecular mass of 23KDa, due to glycosylation, the molecular mass can be between 25-27KDa.

INTENDED USE

Human FGF9 ELISA kit is a reliable quantitative procedure for measuring fibroblast growth factor-9 (FGF-9) in human serum, plasma, body fluids, cell culture supernatant or tissue lysates. This assayhas a minimum sensitivity detection limit of < 15.0 pg/ml.

SENSITIVITY

The minimum sensitivity detection limit of fibroblast growth factor-9 (FGF-9) using this FGF9 ELISA kit was approximately < 15.0 pg/ml. The dynamic assay range for this kit is 62.5 – 4000.0 pg/ml.

REFERENCES

  1. FGF9 on the move. Nat Genet. (2009) 41 (3): 272-3. Spicer D.
  2. Accumulation of FGF9 in prostate cancer correlates with epithelial-to-mesenchymal transition and induction of VEGF-A expression. Anticancer Res. (2014) 34 (2): 695-700. Teishima J., et al.
  3. Autoinhibitory mechanism for the mutation-induced impaired FGF9 signaling. J Chem Inf Model. (2012) 52 (9): 2422-9. Wang Y., et al.
  4. FGF9 is an autocrine and paracrine prostatic growth factor expressed by prostatic stromal cells. J Cell Physiol. (1999) 180 (1): 53-60. Giri D., Ropiquet F. and Ittmann M.

ADDITIONAL INFORMATION

  • Full Name: Fibroblast Growth Factor-9 (FGF9) ELISA Kit
  • Reactivity: Human
  • Sample Type: Serum, Plasma, Body Fluids, Tissue Lysate, Cell Culture Supernatant
  • Sensitivity: < 15.0 pg/ml

OTHER RELATED ELISA KITS

TESTIMONIALS arrow icon

Your secretory IgA ELISA kit gave good results and I was also really impressed with how quickly we received it.

L. Johnston
PhD Student / University of Glasgow

It is refreshing to know that you have a technical team that is very knowledgeable. I have already recommended your company to other researchers in our department.

Dr. P. Anderson
Lecturer / University College London (UCL)

I am a first time user and found that your instruction manual was very easy to follow. The insulin ELISA kit performed well and I was happy with the results that were generated.

J. Thomas
Senior Technician / Addenbrooke’s Hospital

I carried out a pilot study comparing the performance of many ELISA kits from different suppliers and found your kits to be one of the better performers. We observed good linearity and tight replicates.

Dr. C. Davies
Lead Scientists / AstraZeneca

You are my first point of contact when I am looking to purchase ELISA kits. You have such an easy and simple system, yet it is very effective.

A. Shaw
Purchasing / University of Oxford